Emerging evidence suggests that enhanced PKC-α activity in SGCs modulates the calcium channel function, neuroinflammatory responses, and autonomic dysregulation in T2DM, potentially via glial release of factors affecting neuronal excitability [18,51,52,53,54,55]. This evidence concerns the gene PRKCA and type 2 diabetes mellitus.